・Salmeterol/fluticasone combination 39
・Salmeterol 42
・Fluticasone 42
・Placebo 55

UPLIFT: whole population
・Tiotropium 40
・Control 42
UPLIFT: patients with no ICS/LABA
・Tiotropium 40
・Control 47


M. Alifano, A. Cuvelier, A. Delage, N. Roche, B. Lamia, L. C. Molano, L-J Couderc, C-H Marquette, and P. Devillier
Treatment of COPD: from pharmacological to instrumental therapies
Eur. Respir. Rev., March 1, 2010; 19(115): 7 - 23.

The two main goals of the current management of chronic obstructive pulmonary disease (COPD) are: 1) to reduce the impact of the disease on daily activities; and 2) to reduce the risk of future events (exacerbations, lung function decline and death) [1]. The first measure is obviously smoking cessation; however, we will not discuss this.


Update in Chronic Obstructive Pulmonary Disease 2009
Cosio and Agustí Am. J. Respir. Crit. Care Med..2010; 181: 655-66

Update in Pulmonary and Critical Care Medicine

Ann Int Med. May 4, 2010 vol. 152 no. 9 601-608

P. Almagro, M Salvado, C Garcia-Vidal, M Rodriguez-Carballeira, M Delgado, B Barreiro, J L Heredia, and J. B Soriano
Recent improvement in long-term survival after a COPD hospitalisation
Thorax, April 1, 2010; 65(4): 298 - 302.

by internalmedicine | 2010-05-10 10:56 | 呼吸器系  

<< 制酸治療:骨折、C.diffi... 定期的にでる、財政赤字の医療主... >>